Episode Details
Back to EpisodesBiotech CEO on RNAI and Medicine of the Future
Published 1 year, 4 months ago
Description
Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more.
Learn more about your ad choices. Visit megaphone.fm/adchoices